10 Papers Suggested By Wafik S. El-Deiry on July 9

Wafik S. El-Deiry, Director of the Legorreta Cancer Center of Brown University and Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, shared a few must-reads papers on X:                                     .

1. Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes

Authors: Lindsey Wang, Rong Xu, David C. Kaelber and Nathan A. Berger

2. A new Cleveland research center is using AI to improve cancer treatment

Authors: Stephen Langel

3. Area postrema neurons mediate interleukin-6 function in cancer cachexia

Authors: Qingtao Sun, Daniëlle van de Lisdonk, Miriam Ferrer, Bruno Gegenhuber, Melody Wu, Youngkyu Park, David A. Tuveson, Jessica Tollkuhn, Tobias Janowitz and Bo Li

4. Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response

Authors: Brooke A. Pereira, Shona Ritchie, Cecilia R. Chambers, Katie A. Gordon, Astrid Magenau, Kendelle J. Murphy, Max Nobis, Victoria M. Tyma, Ying Fei Liew, Paul Timpson et al.

5. Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy

Authors: Tafadzwa L. Chaunzwa, Jack M. Qian, Qin Li, Biagio Ricciuti, Leonard Nuernberg, Justin W. Johnson, Jakob Weiss, Zhongyi Zhang, Jamie MacKay, Ioannis Kagiampakis, Damian Bikiel, Alessandro Di Federico, Joao V. Alessi, Raymond H. Mak, Etai Jacob, Mark M. Awad, Hugo J. W. L. Aerts.

6. Association of genetic risk, lifestyle, and their interaction with obesity and obesity-related morbidities

Authors: Min Seo Kim, Injeong Shim, Akl C. Fahed, Ron Do, Woong-Yang Park, Pradeep Natarajan, Amit V. Khera, Hong-Hee Won

7. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis

Authors: Andrew E. Whiteley, Danhui Ma, Lihua Wang, Seok-Yeong Yu, Claire Yin, Trevor T. Price, Brennan G. Simon, Katie R. Xu, Kathleen A, Marsh, Dorothy A. Sipkins et al.

8. Saturation genome editing maps the functional spectrum of pathogenic VHL alleles

Authors: Megan Buckley, Chloé Terwagne, Athina Ganner, Laura Cubitt, Reid Brewer, Dong-Kyu Kim, Christina M. Kajba, Nicole Forrester, Phoebe Dace, Joachim De Jonghe, Scott T. C. Shepherd, Chelsea Sawyer, Mairead McEwen, Sven Diederichs, Elke Neumann-Haefelin, Samra Turajlic, Evgueni A. Ivakine and Gregory M. Findlay

9. The Silence Doctors Are Keeping About Millennial Deaths

Authors: Sunita Puri

10. Saturation genome editing of BAP1 functionally classifies somatic and germline variants

Authors: Andrew J. Waters, Timothy Brendler-Spaeth, Danielle Smith, Victoria Offord, Hong Kee Tan, Yajie Zhao, Sofia Obolenski, Maartje Nielsen, Remco van Doorn, Jo-Ellen Murphy, Prashant Gupta, Charlie F. Rowlands, Helen Hanson, Erwan Delage, Mark Thomas, Elizabeth J. Radford, Sebastian S. Gerety, Clare Turnbull, John R. B. Perry, Matthew E. Hurles and David J. Adams

Follow Wafik El-Deiry on X for more such content.

Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center of Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals.

Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.